High body mass index and pre-existing autoimmune disease are associated with an increased risk of immune-related adverse events in cancer patients treated with PD-(L)1 inhibitors across different solid tumors

Thumbnail
Fulltext:
235014.pdf
Size:
423.8Kb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2021
Author(s)
Gulave, B.
Hew, M.N.
Groot, J.S. de
Rodwell, L.
Teerenstra, S.
Fabriek, B.O.
Source
Esmo Open, 6, 3, (2021), article 100107
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/235014   https://hdl.handle.net/2066/235014
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.